Tearsheet

Boston Scientific (BSX)

Market Price (9/16/2025): $99.83 | Market Cap: $147.7 Bil
Sector: Health Care | Industry: Health Care Equipment

Boston Scientific (BSX)

Market Price (9/16/2025): $99.83
Market Cap: $147.7 Bil
Sector: Health Care
Industry: Health Care Equipment

Investment Highlights

0	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%, CFO LTM is 4.3 Bil, FCF LTM is 3.2 Bil		Expensive valuation multiples P/EBITPrice/EBIT or Price/(Operating Income) ratio is 44x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 34x, P/EPrice/Earnings or Price/(Net Income) is 59x
1	Low stock price volatility Vol 12M is 23%		Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.8%

0	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%, CFO LTM is 4.3 Bil, FCF LTM is 3.2 Bil
1	Low stock price volatility Vol 12M is 23%
2	Expensive valuation multiples P/EBITPrice/EBIT or Price/(Operating Income) ratio is 44x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 34x, P/EPrice/Earnings or Price/(Net Income) is 59x
3	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.8%

Market Valuation

	9/16/25	2024	2023	2022	2021
Share Price CYE	$99.83	$89.32	$57.81	$46.27	$42.48
Market Cap CYE ($ Bil)	147.7	131.7	84.7	66.3	60.5
Total Debt ($ Bil)	12.0	11.1	9.5	9.3	9.5
Total Cash ($ Bil)	0.5	0.4	0.9	0.9	1.9
Enterprise Value ($ Bil)	159.2	142.8	94.2	75.6	70.0
Valuation Ratios
P/S TTM	8.0	7.8	5.9	5.2	5.1
P/EBIT TTM	44.4	50.8	37.3	41.1	42.6
P/E TTM	59.0	70.9	52.7	94.8	58.0
Sector Ratios
P/S TTM (Sector)	3.8	3.6	4.1	4.5	7.3
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4	-1.3	-2.9
P/E TTM (Sector)	-1.9	-1.6	-1.5	-1.4	-2.9

	9/16/25	2024	2023
Share Price CYE	$99.83	$89.32	$57.81
Market Cap CYE ($ Bil)	147.7	131.7	84.7
Total Debt ($ Bil)	12.0	11.1	9.5
Total Cash ($ Bil)	0.5	0.4	0.9
Enterprise Value ($ Bil)	159.2	142.8	94.2
Valuation Ratios
P/S TTM	8.0	7.8	5.9
P/EBIT TTM	44.4	50.8	37.3
P/E TTM	59.0	70.9	52.7
Sector Ratios
P/S TTM (Sector)	3.8	3.6	4.1
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4
P/E TTM (Sector)	-1.9	-1.6	-1.5

Stock Price
Market Cap

Stock Price Chart

Return (1Y):

Market Cap Chart

Business Description

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. Show more

Price Returns Compared

Expand for Detailed View

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
BSX Return	-20%	18%	9%	25%	55%	12%	127%
Peers Return	12%	13%	-21%	3%	6%	-3%	7%
S&P 500 Return	16%	27%	-19%	24%	23%	12%	104%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: ABT, ISRG, MDT, BDX, BAX. See BSX Returns vs. Peers.
[3] 2025 data is for the year up to 9/15/2025 (YTD)

Interactive Breakdown

Boston Scientific Interactive Breakdown Analysis

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	Day 5 of Loss Streak for Boston Scientific Stock with -7.6% Return (vs. 12% YTD) [9/15/2025]	Notification
2	Boston Scientific Earnings Notes
3	Boston Scientific vs Eli Lilly: Which Is A Better Investment?	Counter-Intuitive Comparisons
4	How Does BSX Stack Up Against Its Peers?	Peer Comparison
5	Wait For A Dip To Buy Boston Scientific Stock	Buy or Fear
6	Better Bet Than BSX Stock: Pay Less Than Boston Scientific To Get More From LLY, APH
7	Better Bet Than BSX Stock: Pay Less Than Boston Scientific To Get More From LLY, BMRN
8	Better Bet Than BSX Stock: Pay Less Than Boston Scientific To Get More From GMED
9	Better Bet Than BSX Stock: Pay Less Than Boston Scientific To Get More From GMED, UFPT	Actionable
10	BSX Dip Buy Analysis
11	ARTICLES
12	BSX Stock Down -7.6% after 5-Day Loss Streak		September 16th, 2025
13	Wait for a dip to buy Boston Scientific stock		August 13th, 2025
14	Better Bet Than Boston Scientific Stock: Pay Less To Get More From GMED, UFPT		August 2nd, 2025
15	S&P 500 Stocks Trading At 52-Week High		July 24th, 2025
16	Large Cap Stocks Trading At 52-Week High		July 24th, 2025

	Title
0	DASHBOARDS
1	BSX Stock Down -7.6% after 5-Day Loss Streak
2	Wait for a dip to buy Boston Scientific stock
3	Better Bet Than Boston Scientific Stock: Pay Less To Get More From GMED, UFPT
4	S&P 500 Stocks Trading At 52-Week High
5	Large Cap Stocks Trading At 52-Week High
6	ARTICLES
7	Day 5 of Loss Streak for Boston Scientific Stock with -7.6% Return (vs. 12% YTD) [9/15/2025]
8	Boston Scientific Earnings Notes
9	Boston Scientific vs Eli Lilly: Which Is A Better Investment?
10	How Does BSX Stack Up Against Its Peers?
11	Wait For A Dip To Buy Boston Scientific Stock
12	Better Bet Than BSX Stock: Pay Less Than Boston Scientific To Get More From LLY, APH
13	Better Bet Than BSX Stock: Pay Less Than Boston Scientific To Get More From LLY, BMRN
14	Better Bet Than BSX Stock: Pay Less Than Boston Scientific To Get More From GMED
15	Better Bet Than BSX Stock: Pay Less Than Boston Scientific To Get More From GMED, UFPT
16	BSX Dip Buy Analysis

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	NXTT	Next Technology	18947.6%	1080.3%
2	VCIG	VCI Global	2528.6%	-66.8%
3	BDSX	Biodesix	1926.1%	-75.2%
4	CLSD	Clearside Biomedical	1136.3%	-72.3%
5	SDOT	Sadot	1033.9%	-78.2%
6	CHEK	Check-Cap	184.2%	114.2%
7	ATCH	AtlasClear	153.8%	-89.7%
8	HSDT	Helius Medical Technologies	141.7%	-96.4%
9	MTVA	MetaVia	115.5%	-26.1%
10	IHT	InnSuites Hospitality Trust	66.0%	54.9%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	ATYR	aTyr Pharma	-83.2%	-72.0%
2	NAKA	Kindly MD	-55.4%
3	REX	REX American Resources	-49.8%	-26.7%
4	FAAS	DigiAsia	-39.2%	-83.2%
5	EVTV	Envirotech Vehicles	-32.8%	-77.4%
6	WLDS	Wearable Devices	-30.0%	-24.4%
7	ZONE	CleanCore Solutions	-29.5%	107.8%
8	CGTX	Cognition Therapeutics	-29.0%	119.6%
9	SIDU	Sidus Space	-28.7%	-80.8%
10	BNGO	Bionano Genomics	-28.6%	-84.0%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	NXTT	Next Technology	18985.5%	1080.3%
2	BDSX	Biodesix	1658.4%	-75.2%
3	VCIG	VCI Global	1460.0%	-66.8%
4	CLSD	Clearside Biomedical	1075.2%	-72.3%
5	SDOT	Sadot	806.7%	-78.2%
6	WLDS	Wearable Devices	539.8%	-24.4%
7	QMMM	QMMM	536.6%	5505.5%
8	ATCH	AtlasClear	382.9%	-89.7%
9	OPI	Office Properties Income Trust	274.5%	-8.3%
10	CWD	CaliberCos	246.5%	-46.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	DGNX	Diginex	-83.7%
2	ATYR	aTyr Pharma	-81.4%	-72.0%
3	LGCL	Lucas GC	-73.2%	-78.3%
4	NAKA	Kindly MD	-72.8%
5	OCTO	Eightco	-67.8%	562.1%
6	YYGH	YY	-67.0%	-78.2%
7	SNTG	Sentage	-58.1%	57.5%
8	REX	REX American Resources	-50.7%	-26.7%
9	BINI	Bollinger Innovations	-49.2%	-100.0%
10	SLXN	Silexion Therapeutics	-49.2%	-88.0%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	11963.5%	11963.5%
2	GIBO	GIBO	7309.3%
3	CHSN	Chanson International	5551.3%	-99.3%
4	LNZA	LanzaTech Global	5145.9%	-85.7%
5	QMMM	QMMM	2490.3%	5505.5%
6	NXTT	Next Technology	2167.7%	1080.3%
7	VTAK	Catheter Precision	1543.9%	-70.5%
8	CURX	Curanex Pharmaceuticals	1282.0%	1282.0%
9	VCIG	VCI Global	1278.3%	-66.8%
10	OCTO	Eightco	800.6%	562.1%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	CJET	Chijet Motor	-93.3%	-95.1%
2	ELPW	Elong Power	-92.4%	-76.5%
3	STFS	Star Fashion Culture	-92.1%	-97.9%
4	ETS	Elite Express	-92.0%	-92.0%
5	NAKA	Kindly MD	-91.7%
6	BINI	Bollinger Innovations	-90.5%	-100.0%
7	FLYE	Fly-E	-89.8%	-81.2%
8	JEM	707 Cayman	-89.8%	-98.3%
9	NUTR	NusaTrip	-86.7%	-86.7%
10	CUPR	Cuprina	-84.9%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	NXTT	Next Technology	18947.6%	1080.3%
2	VCIG	VCI Global	2528.6%	-66.8%
3	BDSX	Biodesix	1926.1%	-75.2%
4	CLSD	Clearside Biomedical	1136.3%	-72.3%
5	SDOT	Sadot	1033.9%	-78.2%
6	CHEK	Check-Cap	184.2%	114.2%
7	ATCH	AtlasClear	153.8%	-89.7%
8	HSDT	Helius Medical Technologies	141.7%	-96.4%
9	MTVA	MetaVia	115.5%	-26.1%
10	IHT	InnSuites Hospitality Trust	66.0%	54.9%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	ATYR	aTyr Pharma	-83.2%	-72.0%
2	NAKA	Kindly MD	-55.4%
3	REX	REX American Resources	-49.8%	-26.7%
4	FAAS	DigiAsia	-39.2%	-83.2%
5	EVTV	Envirotech Vehicles	-32.8%	-77.4%
6	WLDS	Wearable Devices	-30.0%	-24.4%
7	ZONE	CleanCore Solutions	-29.5%	107.8%
8	CGTX	Cognition Therapeutics	-29.0%	119.6%
9	SIDU	Sidus Space	-28.7%	-80.8%
10	BNGO	Bionano Genomics	-28.6%	-84.0%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	NXTT	Next Technology	18985.5%	1080.3%
2	BDSX	Biodesix	1658.4%	-75.2%
3	VCIG	VCI Global	1460.0%	-66.8%
4	CLSD	Clearside Biomedical	1075.2%	-72.3%
5	SDOT	Sadot	806.7%	-78.2%
6	WLDS	Wearable Devices	539.8%	-24.4%
7	QMMM	QMMM	536.6%	5505.5%
8	ATCH	AtlasClear	382.9%	-89.7%
9	OPI	Office Properties Income Trust	274.5%	-8.3%
10	CWD	CaliberCos	246.5%	-46.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	DGNX	Diginex	-83.7%
2	ATYR	aTyr Pharma	-81.4%	-72.0%
3	LGCL	Lucas GC	-73.2%	-78.3%
4	NAKA	Kindly MD	-72.8%
5	OCTO	Eightco	-67.8%	562.1%
6	YYGH	YY	-67.0%	-78.2%
7	SNTG	Sentage	-58.1%	57.5%
8	REX	REX American Resources	-50.7%	-26.7%
9	BINI	Bollinger Innovations	-49.2%	-100.0%
10	SLXN	Silexion Therapeutics	-49.2%	-88.0%

Peer Comparisons for Boston Scientific

Financials

	BSX	ABT	ISRG	MDT	BDX	BAX	Median
Name	Boston S.	Abbott L.	Intuitiv.	Medtronic	Becton D.	Baxter I.
Mkt Price	99.87	131.33	433.99	93.43	185.74	23.80	115.60
Mkt Cap	147.8	229.0	155.6	119.7	53.3	12.2	133.8
Rev LTM	18,494	43,109	9,145	34,200	21,386	10,887	19,940
Op Inc LTM	3,388	7,515	2,634	6,647	2,955	398	3,172
FCF LTM	3,234	6,775	1,994	5,303	2,550	218	2,892
FCF 3Y Avg	2,114	5,972	1,197	4,964	2,504	658	2,309
CFO LTM	4,285	9,037	2,826	7,146	3,254	765	3,770
CFO 3Y Avg	3,014	8,130	2,116	6,625	3,278	1,166	3,146

Growth & Margins

	BSX	ABT	ISRG	MDT	BDX	BAX	Median
Name	Boston S.	Abbott L.	Intuitiv.	Medtronic	Becton D.	Baxter I.
Rev Chg LTM	21.4%	5.9%	20.8%	5.0%	7.9%	3.6%	6.9%
Rev Chg 3Y Avg	14.6%	-1.5%	15.4%	3.3%	4.1%	-5.7%	3.7%
Rev Chg Q	22.8%	7.4%	21.4%	8.4%	10.4%	4.3%	9.4%
QoQ Delta Rev Chg LTM	5.4%	1.8%	4.9%	2.0%	2.5%	1.1%	2.2%
Op Mgn LTM	18.3%	17.4%	28.8%	19.4%	13.8%	3.7%	17.9%
Op Mgn 3Y Avg	17.6%	16.2%	26.3%	18.6%	13.3%	2.9%	16.9%
QoQ Delta Op Mgn LTM	-0.2%	0.6%	0.6%	-0.1%	0.9%	0.1%	0.3%
CFO/Rev LTM	23.2%	21.0%	30.9%	20.9%	15.2%	7.0%	20.9%
CFO/Rev 3Y Avg	18.8%	19.6%	26.9%	20.2%	16.3%	11.2%	19.2%
FCF/Rev LTM	17.5%	15.7%	21.8%	15.5%	11.9%	2.0%	15.6%
FCF/Rev 3Y Avg	13.1%	14.4%	15.0%	15.1%	12.4%	6.3%	13.7%

Valuation

	BSX	ABT	ISRG	MDT	BDX	BAX	Median
Name	Boston S.	Abbott L.	Intuitiv.	Medtronic	Becton D.	Baxter I.
Mkt Cap	147.8	229.0	155.6	119.7	53.3	12.2	133.8
P/S	8.0	5.3	17.0	3.5	2.5	1.1	4.4
P/EBIT	44.4	27.2	59.1	18.7	21.3	381.5	35.8
P/E	59.0	16.4	59.7	25.7	33.7	-78.8	29.7
P/CFO	34.5	25.3	55.1	16.8	16.4	16.0	21.0
Total Yield	1.7%	7.8%	1.7%	6.9%	5.2%	2.6%	3.9%
Dividend Yield	0.0%	1.7%	0.0%	3.0%	2.2%	3.8%	2.0%
FCF Yield 3Y Avg	1.8%	3.0%	0.8%	4.5%	4.1%	3.5%	3.2%
D/E	0.1	0.1	0.0	0.2	0.4	0.8	0.2
Net D/E	0.1	0.0	-0.0	0.2	0.3	0.7	0.1

Returns

	BSX	ABT	ISRG	MDT	BDX	BAX	Median
Name	Boston S.	Abbott L.	Intuitiv.	Medtronic	Becton D.	Baxter I.
1M Rtn	-3.2%	-0.3%	-9.6%	0.4%	-4.7%	-0.9%	-2.0%
3M Rtn	-1.6%	-1.6%	-16.4%	7.1%	8.5%	-22.2%	-1.6%
6M Rtn	1.0%	3.8%	-11.2%	1.7%	-17.5%	-30.8%	-5.1%
12M Rtn	19.9%	15.0%	-11.4%	7.3%	-19.0%	-38.7%	-2.1%
3Y Rtn	139.5%	33.9%	110.4%	14.4%	-23.1%	-55.7%	24.1%
1M Excs Rtn	-6.4%	-0.7%	-11.3%	-0.7%	-6.5%	-4.2%	-5.3%
3M Excs Rtn	-10.5%	-13.4%	-25.9%	-2.7%	-2.2%	-32.4%	-12.0%
6M Excs Rtn	-14.5%	-12.7%	-27.7%	-15.3%	-34.2%	-47.6%	-21.5%
12M Excs Rtn	1.3%	-4.3%	-30.7%	-12.3%	-38.0%	-57.1%	-21.5%
3Y Excs Rtn	68.7%	-35.0%	36.9%	-47.7%	-90.1%	-121.2%	-41.3%

Comparison Analyses

	Title
0	How Does BSX Stack Up Against Its Peers?
1	Boston Scientific vs. Texas Instruments: With Return Forecast Of 34%, Boston Scientific Is A Better Bet
2	Boston Scientific vs. Intuit: With Return Forecast Of 34%-36%, Both Seem Like Good Bets
3	Boston Scientific vs. Automatic Data Processing: With Return Forecast Of 34%, Boston Scientific Is A Better Bet
4	Boston Scientific vs. Becton Dickinson: With Return Forecast Of 32%, Boston Scientific Is A Better Bet
5	Boston Scientific vs. Abbott Laboratories: With Return Forecast Of 32%, Boston Scientific Is A Better Bet
6	Boston Scientific vs. Medtronic: With Return Forecast Of 32%, Boston Scientific Is A Better Bet
7	Boston Scientific vs. Baxter International: With Return Forecast Of 32%, Boston Scientific Is A Better Bet
8	Boston Scientific vs. Intuitive Surgical: With Return Forecast Of 32%-36%, Both Seem Like Good Bets
9	Boston Scientific vs. EchoStar: With Return Forecast Of 32%, Boston Scientific Is A Better Bet

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End		12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date		2/18/2025	2/20/2024	2/23/2023	2/23/2022	2/23/2021	2/25/2020
Key Financials
Total Revenue	18,494	16,747	14,240	12,682	11,888	9,913	10,735
Ebitda	4,646	3,856	3,446	2,747	2,510	1,405	2,171
Operating Income	3,388	3,002	2,418	2,034	1,824	684	1,740
Net Income	2,505	1,854	1,593	698	1,041	-82	4,700
EPS	1.70	1.26	1.08	0.45	0.69	-0.08	3.38
Growth Rates
Total Revenue Growth	21.4%	17.6%	12.3%	6.7%	19.9%	-7.7%	9.3%
EBITDA Growth	27.4%	11.9%	25.4%	9.4%	78.6%	-35.3%	-15.1%
Operating Income Growth	24.6%	24.2%	18.9%	11.5%	166.7%	-60.7%	4.9%
Net Income Growth	37.1%	16.4%	128.2%	-32.9%	1369.5%	-101.7%	181.3%
Margins
EBITDA Margin	25.1%	23.0%	24.2%	21.7%	21.1%	14.2%	20.2%
Operating Income Margin	18.3%	17.9%	17.0%	16.0%	15.3%	6.9%	16.2%
Net Income Margin	13.5%	11.1%	11.2%	5.5%	8.8%	-0.8%	43.8%
Cash & Debt
Total Cash	534	414	865	928	1,925	1,734	217
Total Debt	12,027	11,147	9,492	9,282	9,451	9,539	10,277
Net Debt / (Cash)	11,493	10,733	8,627	8,354	7,526	7,805	10,060
Cash Flows
Net Cash from Operations	4,285	3,435	2,503	1,526	1,870	1,508	1,836
Free Cash from Operations	3,234	2,365	1,703	914	1,316	1,132	1,375
Returns to Shareholders
Dividends	0	-0	28	55	55	28	-0
Share Repurchases	-0	-0	-0	-0	-0	535	-0

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Filing Date	8/1/2025	5/1/2025	2/18/2025	11/1/2024	8/1/2024	5/1/2024	2/20/2024	11/1/2023	8/3/2023	5/4/2023	2/23/2023	11/3/2022
Key Financials Quarterly
Total Revenue	5,061	4,663	4,561	4,209	4,120	3,856	3,725	3,527	3,599	3,389	3,242	3,170
Ebitda	1,367	1,212	1,013	1,054	808	981	883	976	794	794	754	592
Operating Income	943	937	790	718	799	693	618	609	607	583	527	507
Net Income	797	674	566	468	324	494	505	504	270	314	140	188
EPS	0.54	0.46	0.38	0.32	0.22	0.34	0.34	0.34	0.18	0.21	0.09	0.12
Key Financials TTM
Total Revenue TTM	18,494	17,553	16,746	15,910	15,228	14,707	14,240	13,757	13,400	13,045	12,682	12,567
Ebitda TTM	4,646	4,087	3,856	3,726	3,648	3,634	3,447	3,318	2,934	2,833	2,748	2,490
Operating Income TTM	3,388	3,244	3,000	2,828	2,719	2,527	2,417	2,326	2,224	2,135	2,034	1,986
Net Income TTM	2,505	2,032	1,852	1,791	1,827	1,773	1,593	1,228	912	902	698	653
Growth Rates Quarterly
Total Revenue Growth	22.8%	20.9%	22.4%	19.3%	14.5%	13.8%	14.9%	11.3%	10.9%	12.0%	3.7%	8.1%
EBITDA Growth	69.2%	23.5%	14.7%	8.0%	1.8%	23.6%	17.1%	64.9%	14.6%	12.0%	52.0%	-29.6%
Operating Income Growth	18.0%	35.2%	27.8%	17.9%	31.6%	18.9%	17.3%	20.1%	17.2%	21.0%	10.0%	10.7%
Net Income Growth	146.0%	36.4%	12.1%	-7.1%	20.0%	57.3%	260.7%	168.1%	3.8%	185.5%	47.4%	-55.1%
Margins Quarterly
EBITDA Margin	27.0%	26.0%	22.2%	25.0%	19.6%	25.4%	23.7%	27.7%	22.1%	23.4%	23.3%	18.7%
Operating Income Margin	18.6%	20.1%	17.3%	17.1%	19.4%	18.0%	16.6%	17.3%	16.9%	17.2%	16.3%	16.0%
Net Income Margin	15.7%	14.5%	12.4%	11.1%	7.9%	12.8%	13.6%	14.3%	7.5%	9.3%	4.3%	5.9%
Cash & Debt
Total Cash	534	725	414	2,502	2,913	2,329	865	952	426	570	928	338
Total Debt	12,027	11,708	11,147	11,258	10,936	11,001	9,492	9,299	9,454	9,365	9,282	8,934
Net Debt / (Cash)	11,493	10,983	10,733	8,756	8,023	8,672	8,627	8,347	9,028	8,795	8,354	8,596
Cash Flows Quarterly
FCF from Operations	1,286	541	1,456	1,002	813	164	957	698	658	190	807	470
Cash Flows TTM
FCF from Operations TTM	4,285	3,812	3,435	2,936	2,632	2,477	2,503	2,353	2,125	1,774	1,526	1,197
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	11.6%	11.3%	11.0%	8.0%	10.0%	9.0%	9.9%	8.2%	6.1%	6.6%	3.1%	6.3%
Return on Invested Capital (ROIC) TTM
ROIC TTM	10.3%	9.6%	8.8%	9.1%	9.4%	8.3%	7.8%	6.2%	5.3%	5.4%	5.1%	6.0%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
Cardiovascular	8,714	7,679	6,721	3,876	4,208
MedSurg	5,378	4,855	4,389	3,066	3,307
Impact of foreign currency fluctuations	149	208	766
Other		-60	12	219	81
Rhythm and Neuro				2,752	3,140
Total	14,241	12,682	11,888	9,913	10,736

Operating Income by Segment

$ Mil	2024	2023	2022	2021	2020
Cardiovascular	2,281	1,784	1,572	661	1,137
MedSurg	1,834	1,489	1,368	1,079	1,204
Corporate expenses, including hedging activities and impact of foreign currency fluctuations on	-377	29	67	-405	-264
Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges	-567	-789	-1,070	-1,208	-582
Amortization expense	-828	-803	-741	-789	-699
Other		-60	3	143	56
Rhythm and Neuro				439	666
Total	2,343	1,650	1,199	-80	1,518

Assets by Segment

$ Mil	2024	2021	2020
Goodwill	14,387	9,951	10,176
Other intangible assets, net	6,003	5,917	7,886
Cardiovascular	5,988	2,461	2,535
All other corporate assets	5,869	7,850	6,082
MedSurg	2,888	1,638	1,803
Other		1,133	211
Rhythm and Neuro		1,827	1,873
Total	35,135	30,777	30,566

Price Behavior

Behavior Stats
Betas Matrix

Price Behavior

Market Price	$99.87
Market Cap ($ Bil)	147.8
First Trading Date	05/19/1992
Distance from 52W High	-7.6%
	50 Days	200 Days
DMA Price	$104.76	$100.51
DMA Trend	up	indeterminate
Distance from DMA	-4.7%	-0.6%
	3M	1YR
Volatility	19.7%	23.0%
Downside Capture	110.92	61.59
Upside Capture	46.44	69.01
Correlation (SPY)	29.7%	62.3%

BSX Betas & Captures as of 8/31/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.24	0.63	0.47	0.75	0.72	0.66
Up Beta	0.22	0.80	1.00	0.67	0.68	0.70
Down Beta	-0.24	-0.34	-0.89	0.93	0.87	0.84
Up Capture	35%	68%	44%	60%	66%	33%
Bmk +ve Days	10	22	35	71	142	415
Stock +ve Days	9	18	29	64	135	414
Down Capture	41%	104%	87%	80%	69%	71%
Bmk -ve Days	11	19	27	54	106	334
Stock -ve Days	12	23	33	59	111	334

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	8292025
Short Interest: Shares Quantity	18,992,023
Short Interest: % Change Since 8152025	2.1%
Average Daily Volume	5,896,500
Days-to-Cover Short Interest	3.22
Basic Shares Quantity	1,479,900,000
Short % of Basic Shares	1.3%

Returns Analyses

	Title
0	BSX YTD Stock Return Of 19% Outperforms BDX by 42% and Outperforms ABT by 0.2%
1	Will You Be Comfortable Buying Boston Scientific Stock?
2	Boston Scientific During 2008 Recession vs. 2022 Inflation Shock: BSX Stock Is Now 118% Higher Than Its Pre-Shock High
3	Boston Scientific (BSX) Stock Has 73% Chance Of Rise In The Next One Month
4	Boston Scientific Stock Return Comparison
5	[9/29/2021] Boston Scientific (BSX) Stock Price Forecast: AI Forecasts BSX Stock Price To Be Around $45 In A Month (Up 2.6%)
6	Boston Scientific Total Shareholder Return (TSR): 25.0% in 2023 and 17.2% 3-yr returns (above peer average)

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
7/23/2025	4.5%	3.2%	2.8%
4/23/2025	4.1%	8.1%	10.1%
2/5/2025	1.4%	2.4%	-2.6%
10/23/2024	-0.6%	-3.9%	2.5%
7/24/2024	-1.1%	-5.8%	0.3%
4/24/2024	5.7%	4.2%	9.2%
1/31/2024	3.0%	5.5%	7.8%
10/26/2023	-0.4%	3.3%	11.3%
...
SUMMARY STATS
# Positive	15	15	17
# Negative	9	9	7
Median Positive	3.5%	3.5%	6.3%
Median Negative	-1.3%	-2.9%	-5.9%
Max Positive	6.2%	9.4%	17.4%
Max Negative	-6.2%	-5.8%	-8.2%

	Forward Returns
7/23/2025	4.5%	3.2%	2.8%
4/23/2025	4.1%	8.1%	10.1%
2/5/2025	1.4%	2.4%	-2.6%
10/23/2024	-0.6%	-3.9%	2.5%
7/24/2024	-1.1%	-5.8%	0.3%
4/24/2024	5.7%	4.2%	9.2%
1/31/2024	3.0%	5.5%	7.8%
10/26/2023	-0.4%	3.3%	11.3%
7/27/2023	0.5%	-3.4%	-3.8%
4/26/2023	-0.0%	3.5%	1.6%
2/1/2023	2.8%	4.0%	2.2%
10/26/2022	1.2%	3.5%	6.3%
7/27/2022	6.2%	9.2%	8.4%
4/27/2022	1.1%	-1.9%	-5.9%
2/2/2022	-4.7%	1.5%	1.1%
10/27/2021	-1.3%	-2.5%	-8.2%
7/27/2021	3.5%	4.3%	2.0%
4/28/2021	4.3%	2.2%	-1.4%
1/12/2021	-3.0%	-0.5%	6.6%
10/28/2020	-5.5%	-2.5%	-6.9%
7/29/2020	4.0%	-2.9%	2.8%
3/30/2020	3.4%	1.8%	17.4%
1/14/2020	-6.2%	-3.1%	-7.1%
10/23/2019	5.0%	9.4%	11.6%
SUMMARY STATS
# Positive	15	15	17
# Negative	9	9	7
Median Positive	3.5%	3.5%	6.3%
Median Negative	-1.3%	-2.9%	-5.9%
Max Positive	6.2%	9.4%	17.4%
Max Negative	-6.2%	-5.8%	-8.2%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
6302025	8012025	10-Q 6/30/2025
3312025	5012025	10-Q 3/31/2025
12312024	2182025	10-K 12/31/2024
9302024	11012024	10-Q 9/30/2024
6302024	8012024	10-Q 6/30/2024
3312024	5012024	10-Q 3/31/2024
12312023	2202024	10-K 12/31/2023
9302023	11012023	10-Q 9/30/2023
6302023	8032023	10-Q 6/30/2023
3312023	5042023	10-Q 3/31/2023
12312022	2232023	10-K 12/31/2022
9302022	11032022	10-Q 9/30/2022
6302022	8042022	10-Q 6/30/2022
3312022	5052022	10-Q 3/31/2022
12312021	2232022	10-K 12/31/2021
9302021	11042021	10-Q 9/30/2021

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	FUJIMORI YOSHIAKI		7302025	Sell	106.99	2,901	310,378	222,646	Form
1	LUDWIG EDWARD J		7282025	Sell	106.03	4,000	424,120	1,959,330	Form
2	LUDWIG EDWARD J		5302025	Sell	104.59	4,000	418,368	2,351,121	Form
3	Brown Vance R	SVP, GC and Corp. Secretary	5222025	Sell	106.42	4,826	513,583	3,338,076	Form
4	Brown Vance R	SVP, GC and Corp. Secretary	4222025	Sell	95.09	4,826	458,904	3,441,592	Form

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

Health Care Equipment Resources

MedTech Dive

MassDevice

Fierce Medical Devices

Medical Device and Diagnostic Industry

MD+DI

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Boston Scientific (BSX)

Market Price (9/16/2025): $99.83 | Market Cap: $147.7 BilSector: Health Care | Industry: Health Care Equipment

Boston Scientific (BSX)

Market Price (9/16/2025): $99.83Market Cap: $147.7 BilSector: Health CareIndustry: Health Care Equipment

Investment Highlights

Market Valuation

Stock Price Chart

Market Cap Chart

Business Description

Price Returns Compared

Interactive Breakdown

Better Bets than Boston Scientific (BSX)

Latest Trefis Analyses

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Boston Scientific

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (9/16/2025): $99.83 | Market Cap: $147.7 Bil
Sector: Health Care | Industry: Health Care Equipment

Market Price (9/16/2025): $99.83
Market Cap: $147.7 Bil
Sector: Health Care
Industry: Health Care Equipment